Cellcentric Ltd.
Clinical trials sponsored by Cellcentric Ltd., explained in plain language.
-
New hope for hard-to-treat blood cancers?
Disease control Recruiting nowThis early-stage trial is testing a new drug called CCS1477 in people with advanced blood cancers such as leukemia, lymphoma, and multiple myeloma. The study aims to see if the drug is safe and can shrink tumors. About 250 participants will receive the drug alone or with other tr…
Phase: PHASE1, PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated May 01, 2026 20:57 UTC
-
New hope for hard-to-treat myeloma: triple drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug called inobrodib combined with two standard medicines (pomalidomide and dexamethasone) in 100 adults whose multiple myeloma has come back or no longer responds to available therapies. The goal is to see how well the combination shrinks tumors and to le…
Phase: PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC